A recombinant live attenuated tetravalent vaccine for the prevention of dengue
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A recombinant live attenuated tetravalent vaccine for the prevention of dengue
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume 16, Issue 7, Pages 671-683
Publisher
Informa UK Limited
Online
2017-06-08
DOI
10.1080/14760584.2017.1335201
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vaccination Against Dengue: Challenges and Current Developments
- (2016) Bruno Guy et al. Annual Review of Medicine
- Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2–16 Years in Asia and Latin America
- (2016) Gustavo Olivera-Botello et al. JOURNAL OF INFECTIOUS DISEASES
- Is discussion of dengue vaccination for the 2016 Olympics necessary?
- (2016) Jose L Arredondo-García et al. LANCET
- The global economic burden of dengue: a systematic analysis
- (2016) Donald S Shepard et al. LANCET INFECTIOUS DISEASES
- Symptomatic Dengue in Children in 10 Asian and Latin American Countries
- (2016) Maïna L’Azou et al. NEW ENGLAND JOURNAL OF MEDICINE
- Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment
- (2016) Neil M. Ferguson et al. SCIENCE
- Potential impact of dengue vaccination: Insights from two large-scale phase III trials with a tetravalent dengue vaccine
- (2016) Laurent Coudeville et al. VACCINE
- Answer to the review from Halstead and Russell “Protective and immunological behavior of chimeric yellow fever dengue vaccine” (DOI 10.1016/j.vaccine.2016.02.004)
- (2016) Sri Rezki S. Hadinegoro et al. VACCINE
- The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study
- (2016) Stefan Flasche et al. PLOS MEDICINE
- Cytokine Profile of Children Hospitalized with Virologically-Confirmed Dengue during Two Phase III Vaccine Efficacy Trials
- (2016) Anke Harenberg et al. PLoS Neglected Tropical Diseases
- Safety Overview of a Recombinant Live-Attenuated Tetravalent Dengue Vaccine: Pooled Analysis of Data from 18 Clinical Trials
- (2016) Sophia Gailhardou et al. PLoS Neglected Tropical Diseases
- Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial
- (2015) Sarah L. George et al. JOURNAL OF INFECTIOUS DISEASES
- Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults
- (2015) Beth D. Kirkpatrick et al. JOURNAL OF INFECTIOUS DISEASES
- Dengue
- (2015) Maria G Guzman et al. LANCET
- Dengue vaccine: hypotheses to understand CYD-TDV-induced protection
- (2015) Bruno Guy et al. NATURE REVIEWS MICROBIOLOGY
- Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
- (2015) Sri Rezeki Hadinegoro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
- (2015) Luis Villar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Asymptomatic humans transmit dengue virus to mosquitoes
- (2015) Veasna Duong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forward
- (2015) Bruno Guy et al. VACCINE
- Lot-to-lot consistency of a tetravalent dengue vaccine in healthy adults in Australia: A randomised study
- (2015) Joseph Torresi et al. VACCINE
- Immunogenicity and safety of a tetravalent dengue vaccine in healthy adults in India: A randomized, observer-blind, placebo-controlled phase II trial
- (2015) Anand Prakash Dubey et al. Human Vaccines & Immunotherapeutics
- Influence of FcγRIIa-Expressing Cells on the Assessment of Neutralizing and Enhancing Serum Antibodies Elicited by a Live-Attenuated Tetravalent Dengue Vaccine
- (2015) Anthony M. Byers et al. Open Forum Infectious Diseases
- Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
- (2014) Maria Rosario Capeding et al. LANCET
- Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naïve adults in Mexico
- (2014) Gustavo H Dayan et al. Human Vaccines & Immunotherapeutics
- Immunogenicity and Safety of a Recombinant Tetravalent Dengue Vaccine in Children and Adolescents Ages 9–16 Years in Brazil
- (2013) Gustavo H. Dayan et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- The global distribution and burden of dengue
- (2013) Samir Bhatt et al. NATURE
- Safety and Immunogenicity of a Recombinant Tetravalent Dengue Vaccine in 9–16 Year Olds
- (2013) Luis Á. Villar et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Safety and immunogenicity of a tetravalent dengue vaccine in healthy children aged 2–11 years in Malaysia: A randomized, placebo-controlled, Phase III study
- (2013) Amar-Singh HSS et al. VACCINE
- Safety and immunogenicity of three tetravalent dengue vaccine formulations in healthy adults in the USA
- (2013) Gustavo H. Dayan et al. VACCINE
- Persistence of Th1/Tc1 responses one year after tetravalent dengue vaccination in adults and adolescents in Singapore
- (2013) Anke Harenberg et al. Human Vaccines & Immunotherapeutics
- Epidemiological Trends of Dengue Disease in Brazil (2000–2010): A Systematic Literature Search and Analysis
- (2013) Maria Glória Teixeira et al. PLoS Neglected Tropical Diseases
- Nomenclature for Immune Correlates of Protection After Vaccination
- (2012) S. A. Plotkin et al. CLINICAL INFECTIOUS DISEASES
- Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
- (2012) Arunee Sabchareon et al. LANCET
- Immunogenicity and safety of tetravalent dengue vaccine in 2–11 year-olds previously vaccinated against yellow fever: Randomized, controlled, phase II study in Piura, Peru
- (2012) Claudio F. Lanata et al. VACCINE
- DengueTools: innovative tools and strategies for the surveillance and control of dengue
- (2012) Annelies Wilder-Smith et al. Global Health Action
- Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2–45 years
- (2012) Yee Sin Leo et al. Human Vaccines & Immunotherapeutics
- Priming Effect of Dengue and Yellow Fever Vaccination on the Immunogenicity, Infectivity, and Safety of a Tetravalent Dengue Vaccine in Humans
- (2011) Ming Qiao et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Development of DENVax: A chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever
- (2011) Jorge E. Osorio et al. VACCINE
- Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: Randomized controlled phase I trial in the Philippines
- (2011) Rosario Z. Capeding et al. VACCINE
- Next generation dengue vaccines: A review of candidates in preclinical development
- (2011) Julia Schmitz et al. VACCINE
- The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease
- (2011) Beth-Ann G. Coller et al. VACCINE
- From research to phase III: Preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine
- (2011) Bruno Guy et al. VACCINE
- Correlates of Protection Induced by Vaccination
- (2010) S. A. Plotkin Clinical and Vaccine Immunology
- A Novel Tetravalent Dengue Vaccine Is Well Tolerated and Immunogenic against All 4 Serotypes inFlavivirus‐Naive Adults
- (2010) Dennis Morrison et al. JOURNAL OF INFECTIOUS DISEASES
- Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes
- (2010) Scott B Halstead et al. LANCET INFECTIOUS DISEASES
- Live-attenuated Tetravalent Dengue Vaccine in Dengue-naïve Children, Adolescents, and Adults in Mexico City
- (2010) Jorge Poo et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Severe dengue: questioning the paradigm
- (2009) Bernadette Murgue MICROBES AND INFECTION
- Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses
- (2009) Bruno Guy et al. VACCINE
- A Prospective Nested Case-Control Study of Dengue in Infants: Rethinking and Refining the Antibody-Dependent Enhancement Dengue Hemorrhagic Fever Model
- (2009) Daniel H. Libraty et al. PLOS MEDICINE
- Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects
- (2008) Bruno Guy et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search